Wells Fargo & Company MN raised its holdings in Orthofix International NV (NASDAQ:OFIX) by 44.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 39,997 shares of the medical device company’s stock after buying an additional 12,248 shares during the quarter. Wells Fargo & Company MN owned 0.22% of Orthofix International worth $2,188,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the business. Candriam Luxembourg S.C.A. increased its holdings in Orthofix International by 60.5% in the 4th quarter. Candriam Luxembourg S.C.A. now owns 12,612 shares of the medical device company’s stock valued at $690,000 after buying an additional 4,755 shares during the period. California Public Employees Retirement System increased its holdings in Orthofix International by 10.0% in the 4th quarter. California Public Employees Retirement System now owns 61,942 shares of the medical device company’s stock valued at $3,388,000 after buying an additional 5,632 shares during the period. Teacher Retirement System of Texas bought a new stake in Orthofix International in the 4th quarter valued at $339,000. Cadence Capital Management LLC grew its holdings in shares of Orthofix International by 7.8% in the 4th quarter. Cadence Capital Management LLC now owns 34,228 shares of the medical device company’s stock worth $1,872,000 after purchasing an additional 2,467 shares during the last quarter. Finally, Crossmark Global Holdings Inc. bought a new stake in shares of Orthofix International in the 4th quarter worth about $260,000. 94.75% of the stock is currently owned by hedge funds and other institutional investors.
Several research firms have recently weighed in on OFIX. BidaskClub lowered shares of Orthofix International from a “hold” rating to a “sell” rating in a report on Thursday, February 15th. ValuEngine raised shares of Orthofix International from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Gabelli reaffirmed a “buy” rating on shares of Orthofix International in a report on Wednesday, February 28th. TheStreet raised shares of Orthofix International from a “c+” rating to a “b” rating in a report on Tuesday, March 20th. Finally, SunTrust Banks upped their target price on shares of Orthofix International to $67.00 and gave the stock a “buy” rating in a report on Monday, March 5th. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. Orthofix International has a consensus rating of “Buy” and a consensus target price of $57.42.
OFIX opened at $59.49 on Friday. Orthofix International NV has a twelve month low of $36.90 and a twelve month high of $61.00. The stock has a market capitalization of $1,098.78, a PE ratio of 36.72, a PEG ratio of 3.35 and a beta of 0.24.
Orthofix International (NASDAQ:OFIX) last posted its earnings results on Monday, February 26th. The medical device company reported $0.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.02. Orthofix International had a net margin of 1.43% and a return on equity of 10.66%. The business had revenue of $116.90 million for the quarter, compared to analyst estimates of $116.93 million. During the same quarter in the prior year, the firm earned $0.42 EPS. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. research analysts expect that Orthofix International NV will post 1.84 earnings per share for the current year.
About Orthofix International
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.